RE:InjectorYear3000 as usual just enough of vagueness so that you don't really have any precise answers. Do the mean completing development of the device by the end of 2023 or just sometime in 2023 which by the way is running out of time. Securing a contract manufacturer I heard this at the AGM in September 2 1/2 months ago so that has not gone anywhere. My disappointment is in Mainpointe who were supposed to coordinate and finance the device to FDA Approval. That obviously has not happened.
Instead of hearing something about the Dermal Injector I think what we will hear next is about what they are presntly working on:
Partnering with a large Pharma to market RCH-01
Sell the global rights to RCH-01 to a large Pharma (possibly Shiseido)
Selling the company and all assets to a large Pharma
I certainly hope it is one of the above rather than some vague update on the Dermal Injector targeted to be marketed sometime in late 2024 or beyond.